StonvexLoading…
StonvexStonvexStonvexCore line items from ALGT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $671.80M | $2.32B | $1.73B | $1.23B |
Operating Income | $81.10M | $37.17M | $-29.68M | $-2.49M |
Net Income | $42.48M | $-44.70M | $-76.64M | $-33.06M |
EPS (Diluted) | $2.30 | $-2.48 | $-4.26 | $-1.84 |
Total Assets | $4.41B | $4.21B | $4.39B | $4.39B |
Total Liabilities | $3.32B | $3.16B | $3.38B | $3.33B |
Cash & Equivalents | $283.45M | $172.70M | $316.22M | $209.87M |
Free Cash Flow OCF − CapEx | $222.64M | $75.10M | $-15.31M | $106.42M |
Shares Outstanding | 18.21M | 18.05M | 18.01M | 17.99M |